DSIP 5mg — Research Protocol

Quickstart Highlights

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its effects on sleep architecture and stress modulation^[1][2]. Research indicates DSIP may promote delta-wave (slow-wave) sleep, modulate cortisol and ACTH levels, and exhibit stress-protective properties^[3][4].

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure^[8].
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~4 weeks and avoid freeze–thaw^[9].
• Allow vials to reach room temperature before opening to reduce condensation uptake.

How It Works

DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain^[1]. Mechanistic studies suggest DSIP may influence sleep by modulating GABAergic transmission and interacting with opioid receptor systems^[10]. Research indicates it can increase delta-wave (slow-wave) sleep duration without significantly altering REM sleep architecture^[3]. Beyond sleep, DSIP has demonstrated stress-protective and adaptogenic properties in various models, potentially through modulation of the hypothalamic-pituitary-adrenal axis^[4][11].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

• May promote deeper, more restorative slow-wave sleep and improve subjective sleep quality^[3][5].
• Research suggests potential stress-protective and anxiolytic-like effects^[4][11].
• Some studies indicate DSIP does not induce pharmacological tolerance with continued use^[2].
• Generally well tolerated in human studies; occasional mild injection-site reactions may occur with subcutaneous administration.
• Limited long-term safety data; periodic breaks are recommended as a precaution^[6].

References

• Schoenenberger GA, Monnier M (1977)Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci USA
• European Journal of Anaesthesiology (2001)Delta sleep-inducing peptide: editorial review of mechanisms and clinical context
• Schneider-Helmert D, Schoenenberger GA (1983)Effects of DSIP in man: multifunctional psychophysiological properties. Neuropsychobiology
• Sudakov KV et al. (2004)Delta-sleep-inducing peptide sequelae: stress protective effect. Ann N Y Acad Sci
• Schneider-Helmert D (1981)Acute and delayed effects of DSIP on human sleep behavior. Int J Clin Pharmacol Ther Toxicol
• Graf MV, Kastin AJ (1984)Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev
• Iyer KS et al. (1988)Sleep-inducing effect of low doses of DSIP in rats. Indian J Exp Biol
• Manning MC et al. (2010)Stability of protein pharmaceuticals: an update. Pharm Res
• Wang W (2000)Lyophilization and development of solid protein pharmaceuticals. Int J Pharm
• Yehuda S, Carasso RL (1988)DSIP: brain mechanisms and function. Int J Neurosci
• Khvatova EM et al. (2003)Delta sleep-inducing peptide: effect on oxidative stress in brain during different models. Biull Eksp Biol Med
• CDCVaccine administration: subcutaneous route (angle/site; no aspiration)
• NCBI BookshelfMedication Administration: Subcutaneous Injections (Open RN Nursing Skills)